Chart-Typ:
Zeitraum:
| Riot Platforms, Inc.: Riot Announces December 2025 Production and Operations Updates | CASTLE ROCK, Colo., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Riot Platforms, Inc. (NASDAQ: RIOT) ("Riot" or "the Company"), a Bitcoin-driven industry leader in the development of large-scale data centers... ► Artikel lesen |
| Riot Platforms, Inc.: Riot Platforms Announces Chief Financial Officer Transition | CASTLE ROCK, Colo., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Riot Platforms, Inc. (NASDAQ: RIOT) ("Riot" or the "Company") today announced the appointment of Jason Chung as Chief Financial Officer of the... ► Artikel lesen |
| Riot Platforms, Inc.: Riot Announces November 2025 Production and Operations Updates | CASTLE ROCK, Colo., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Riot Platforms, Inc. (NASDAQ: RIOT) ("Riot" or "the Company"), a Bitcoin-driven industry leader in the development of large-scale data centers... ► Artikel lesen |
| Electra Battery Materials Corporation Provides Update on Refinery Project Progress | TORONTO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) ("Electra" or the "Company"), a leader in advancing North America's critical minerals processing... ► Artikel lesen |
| Electra Battery Materials Corporation Signs Agreement with North American pCAM Company | TORONTO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) ("Electra" or the "Company"), a leader in advancing North America's critical minerals processing... ► Artikel lesen |
| Electra Battery Materials Corporation Files Third Quarter 2025 Financial Reports | TORONTO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) ("Electra" or the "Company") announces the filing of its financial results for the third... ► Artikel lesen |
| BioCryst Pharmaceuticals, Inc.: BioCryst Completes Acquisition of Astria Therapeutics, Expanding Leadership in Hereditary Angioedema | RESEARCH TRIANGLE PARK, N.C., Jan. 23, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has completed its acquisition of Astria Therapeutics, Inc., initially... ► Artikel lesen |
| Astria Therapeutics, Inc.: Stockholders Vote to Approve Acquisition by BioCryst Pharmaceuticals, Inc. | BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq: ATXS) today announced that at the special meeting of Astria's stockholders held on January 21, 2026, Astria's stockholders voted to approve... ► Artikel lesen |
| BioCryst Pharmaceuticals, Inc.: BioCryst Announces Preliminary Full Year 2025 ORLADEYO (berotralstat) Net Revenue of $601 Million (+37 percent y-o-y), Beating Prior Guidance Range | -Excluding European ORLADEYO revenue for the full year 2025, preliminary 2025 ORLADEYO net revenue was $563 million (+43 percent y-o-y on a comparable basis)- -ORLADEYO net revenue expected to be... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu RAPPORT THERAPEUTICS INC finden Sie auf Wallstreet Online.